(63) found that metavert, a molecule that inhibits both GSK3B and HDACs activity, could significantly reduce tumour size, prevent metastasis, increase the killing of paclitaxel- and gemcitabine-resistant pancreatic cancer cells. This evidence concerns the gene GSK3B and neoplasm.